These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17948280)

  • 61. Altered immunity accompanies disease progression in a mouse model of prostate dysplasia.
    Tien AH; Xu L; Helgason CD
    Cancer Res; 2005 Apr; 65(7):2947-55. PubMed ID: 15805298
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
    Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
    Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in lymphocyte subsets and cytokines during European porcine reproductive and respiratory syndrome: increased expression of IL-12 and IL-10 and proliferation of CD4(-)CD8(high).
    Gómez-Laguna J; Salguero FJ; De Marco MF; Pallarés FJ; Bernabé A; Carrasco L
    Viral Immunol; 2009 Jul; 22(4):261-71. PubMed ID: 19594397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis.
    Turesson C; Matteson EL; Colby TV; Vuk-Pavlovic Z; Vassallo R; Weyand CM; Tazelaar HD; Limper AH
    Arthritis Rheum; 2005 Jan; 52(1):73-9. PubMed ID: 15641082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.
    Korn S; Wiewrodt R; Walz YC; Becker K; Mayer E; Krummenauer F; Buhl R
    Am J Respir Cell Mol Biol; 2005 Feb; 32(2):142-8. PubMed ID: 15539458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of natural killer cells and T-lymphocyte subsets in peripheral blood, gallbladder cancer and surrounding tissue.
    Liu G; Ren H; Sun XJ; Shi JS
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):81-6. PubMed ID: 17287172
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells.
    Rutella S; Rumi C; Lucia MB; Barberi T; Puggioni PL; Lai M; Romano A; Cauda R; Leone G
    Cytometry; 1999 Jun; 38(3):95-101. PubMed ID: 10397327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle.
    Fogar P; Basso D; Fadi E; Greco E; Pantano G; Padoan A; Bozzato D; Facco M; Sanzari MC; Teolato S; Zambon CF; Navaglia F; Semenzato G; Pedrazzoli S; Plebani M
    Pancreas; 2011 Oct; 40(7):1131-7. PubMed ID: 21792088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
    Clark GJ; Rao M; Ju X; Hart DN
    J Leukoc Biol; 2007 Nov; 82(5):1126-35. PubMed ID: 17702825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of CD69 on T-cell subsets in HIV-1 disease.
    Pitsios C; Dimitrakopoulou A; Tsalimalma K; Kordossis T; Choremi-Papadopoulou H
    Scand J Clin Lab Invest; 2008; 68(3):233-41. PubMed ID: 17917998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perforin expression in peripheral blood lymphocytes and skin-infiltrating cells in patients with lichen planus.
    Prpić Massari L; Kastelan M; Gruber F; Laskarin G; Sotosek Tokmadzić V; Strbo N; Zamolo G; Zauhar G; Rukavina D
    Br J Dermatol; 2004 Aug; 151(2):433-9. PubMed ID: 15327551
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B].
    Zou ZS; Xu DP; Li BS; Huang L; Fu JL; Zhang Z; Jin L; Liu QF; Zhang H; Xin SJ; Wang FS
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2416-9. PubMed ID: 18036321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. T-cell homing receptor expression in IgA nephropathy.
    Batra A; Smith AC; Feehally J; Barratt J
    Nephrol Dial Transplant; 2007 Sep; 22(9):2540-8. PubMed ID: 17452405
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
    Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
    Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
    Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.